Table 2.
Asthmatic (n = 50) | Control (n = 50) | t | P | |
---|---|---|---|---|
Serum IgE (kU/L) | 325 ± 103 | 100.8 ± 60.8 | 13 | <0.001* |
Blood eosinophils (%) | 5.9 ± 2.1 | 2.0 ± 0.9 | 12.5 | <0.001* |
Free carnitine (umol/L) | 30.3 ± 1.8 | 39.3 ± 3.8 | 14.5 | <0.001* |
Total carnitine (umol/L) | 40.1 ± 2.6 | 49.5 ± 3.9 | 12.8 | <0.001* |
(*) P < 0.05 is significant.
The table showed serum IgE, blood eosinophils %, free and total serum carnitine in patient and control groups before starting the L-Carnitine therapy. The serum IgE and blood eosinophils were significantly higher in asthmatic than in control children. On the other hand, the free and total serum carnitine levels were significantly lower in asthmatic than in control children.